Efficacy of combination therapy with zoledronic acid and cetuximab for unresectable rectal cancer with bone metastases: A case report

The combination of cetuximab (CTX) and chemotherapy, such as FOLFOX or FOLFIRI, is currently the standard treatment for metastatic colorectal cancer (mCRC). Zoledronic acid (ZOL) is used in patients with bone metastasis. We herein report our experience with the case of a 58-year-old male patient wit...

Full description

Saved in:
Bibliographic Details
Published in:Mol Clin Oncol
Main Authors: Tokumaru, Yoshihisa, Matsuhashi, Nobuhisa, Takahashi, Takao, Tanahashi, Toshiyuki, Matsui, Satoshi, Imai, Hisashi, Tanaka, Yoshihiro, Yamaguchi, Kazuya, Yoshida, Kazuhiro
Format: Artigo
Language:Inglês
Published: D.A. Spandidos 2019
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6482389/
https://ncbi.nlm.nih.gov/pubmed/31031973
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2019.1836
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items